Extranodal extension of lymph node metastasis is a marker of poor prognosis in oesophageal cancer: A systematic review with meta-analysis

Claudio Luchini, Laura D. Wood, Liang Cheng, Alessia Nottegar, Brendon Stubbs, Marco Solmi, Paola Capelli, Antonio Pea, Giuseppe Sergi, Enzo Manzato, Matteo Fassan, Fabio Bagante, Elfriede Bollschweiler, Simone Giacopuzzi, Takuma Kaneko, Giovanni de Manzoni, Mattia Barbareschi, Aldo Scarpa, Nicola Veronese

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The extranodal extension (ENE) of nodal metastasis is the extension of neoplastic cells through the nodal capsule into the perinodal adipose tissue. This histological feature has recently been indicated as an important prognostic factor in different types of malignancies; in this manuscript, we aim at defining its role in the prognosis of oesophageal cancer with the tool of meta-analysis. Two independent authors searched SCOPUS and PubMed until 31 August 2015 without language restrictions. The studies with available data about prognostic parameters in subjects with oesophageal cancer, comparing patients with the presence of ENE (ENE+) versus only intranodal extension (ENE-), were considered as eligible. Data were summarised using risk ratios (RRs) for number of deaths/ recurrences and HRs together with 95% CIs for timedependent risk related to ENE+, adjusted for potential confounders. Fourteen studies were selected; they followed-up 1437 patients with oesophageal cancer for a median follow-up of 39.4 months. The presence of ENE was associated with a significantly increased risk of all-cause mortality (RR=1.33; 95% CI 1.18 to 1.50, p<0.0001, I2=49%; HR=2.72, 95% CI 2.03 to 3.64, p<0.0001, I2=0%), cancer-specific mortality (RR=1.35; 95% CI 1.14 to 1.59, p=0.001, I2=57%; HR=1.97, 95% CI 1.41 to 2.75, p<0.0001, I2=41%) and of risk of recurrence (RR=1.50, 95% CI 1.20 to 1.88, p<0.0001, I2=9%; HR=2.27, 95% CI 1.72 to 2.90, p<0.0001, I2=0%). On the basis of these results, in oesophageal cancer, ENE should be considered from the gross sampling to the pathology report, and in future oncological staging system.

Original languageEnglish (US)
JournalJournal of Clinical Pathology
DOIs
StateAccepted/In press - Jul 7 2016

Fingerprint

Esophageal Neoplasms
Meta-Analysis
Lymph Nodes
Odds Ratio
Neoplasm Metastasis
Recurrence
Mortality
PubMed
Capsules
Adipose Tissue
Neoplasms
Language
Pathology

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medicine(all)

Cite this

Extranodal extension of lymph node metastasis is a marker of poor prognosis in oesophageal cancer : A systematic review with meta-analysis. / Luchini, Claudio; Wood, Laura D.; Cheng, Liang; Nottegar, Alessia; Stubbs, Brendon; Solmi, Marco; Capelli, Paola; Pea, Antonio; Sergi, Giuseppe; Manzato, Enzo; Fassan, Matteo; Bagante, Fabio; Bollschweiler, Elfriede; Giacopuzzi, Simone; Kaneko, Takuma; de Manzoni, Giovanni; Barbareschi, Mattia; Scarpa, Aldo; Veronese, Nicola.

In: Journal of Clinical Pathology, 07.07.2016.

Research output: Contribution to journalArticle

Luchini, C, Wood, LD, Cheng, L, Nottegar, A, Stubbs, B, Solmi, M, Capelli, P, Pea, A, Sergi, G, Manzato, E, Fassan, M, Bagante, F, Bollschweiler, E, Giacopuzzi, S, Kaneko, T, de Manzoni, G, Barbareschi, M, Scarpa, A & Veronese, N 2016, 'Extranodal extension of lymph node metastasis is a marker of poor prognosis in oesophageal cancer: A systematic review with meta-analysis', Journal of Clinical Pathology. https://doi.org/10.1136/jclinpath-2016-203830
Luchini, Claudio ; Wood, Laura D. ; Cheng, Liang ; Nottegar, Alessia ; Stubbs, Brendon ; Solmi, Marco ; Capelli, Paola ; Pea, Antonio ; Sergi, Giuseppe ; Manzato, Enzo ; Fassan, Matteo ; Bagante, Fabio ; Bollschweiler, Elfriede ; Giacopuzzi, Simone ; Kaneko, Takuma ; de Manzoni, Giovanni ; Barbareschi, Mattia ; Scarpa, Aldo ; Veronese, Nicola. / Extranodal extension of lymph node metastasis is a marker of poor prognosis in oesophageal cancer : A systematic review with meta-analysis. In: Journal of Clinical Pathology. 2016.
@article{7ede2dc6655741cbb260b79baac7d9a1,
title = "Extranodal extension of lymph node metastasis is a marker of poor prognosis in oesophageal cancer: A systematic review with meta-analysis",
abstract = "The extranodal extension (ENE) of nodal metastasis is the extension of neoplastic cells through the nodal capsule into the perinodal adipose tissue. This histological feature has recently been indicated as an important prognostic factor in different types of malignancies; in this manuscript, we aim at defining its role in the prognosis of oesophageal cancer with the tool of meta-analysis. Two independent authors searched SCOPUS and PubMed until 31 August 2015 without language restrictions. The studies with available data about prognostic parameters in subjects with oesophageal cancer, comparing patients with the presence of ENE (ENE+) versus only intranodal extension (ENE-), were considered as eligible. Data were summarised using risk ratios (RRs) for number of deaths/ recurrences and HRs together with 95{\%} CIs for timedependent risk related to ENE+, adjusted for potential confounders. Fourteen studies were selected; they followed-up 1437 patients with oesophageal cancer for a median follow-up of 39.4 months. The presence of ENE was associated with a significantly increased risk of all-cause mortality (RR=1.33; 95{\%} CI 1.18 to 1.50, p<0.0001, I2=49{\%}; HR=2.72, 95{\%} CI 2.03 to 3.64, p<0.0001, I2=0{\%}), cancer-specific mortality (RR=1.35; 95{\%} CI 1.14 to 1.59, p=0.001, I2=57{\%}; HR=1.97, 95{\%} CI 1.41 to 2.75, p<0.0001, I2=41{\%}) and of risk of recurrence (RR=1.50, 95{\%} CI 1.20 to 1.88, p<0.0001, I2=9{\%}; HR=2.27, 95{\%} CI 1.72 to 2.90, p<0.0001, I2=0{\%}). On the basis of these results, in oesophageal cancer, ENE should be considered from the gross sampling to the pathology report, and in future oncological staging system.",
author = "Claudio Luchini and Wood, {Laura D.} and Liang Cheng and Alessia Nottegar and Brendon Stubbs and Marco Solmi and Paola Capelli and Antonio Pea and Giuseppe Sergi and Enzo Manzato and Matteo Fassan and Fabio Bagante and Elfriede Bollschweiler and Simone Giacopuzzi and Takuma Kaneko and {de Manzoni}, Giovanni and Mattia Barbareschi and Aldo Scarpa and Nicola Veronese",
year = "2016",
month = "7",
day = "7",
doi = "10.1136/jclinpath-2016-203830",
language = "English (US)",
journal = "Journal of Clinical Pathology - Clinical Molecular Pathology",
issn = "0021-9746",
publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Extranodal extension of lymph node metastasis is a marker of poor prognosis in oesophageal cancer

T2 - A systematic review with meta-analysis

AU - Luchini, Claudio

AU - Wood, Laura D.

AU - Cheng, Liang

AU - Nottegar, Alessia

AU - Stubbs, Brendon

AU - Solmi, Marco

AU - Capelli, Paola

AU - Pea, Antonio

AU - Sergi, Giuseppe

AU - Manzato, Enzo

AU - Fassan, Matteo

AU - Bagante, Fabio

AU - Bollschweiler, Elfriede

AU - Giacopuzzi, Simone

AU - Kaneko, Takuma

AU - de Manzoni, Giovanni

AU - Barbareschi, Mattia

AU - Scarpa, Aldo

AU - Veronese, Nicola

PY - 2016/7/7

Y1 - 2016/7/7

N2 - The extranodal extension (ENE) of nodal metastasis is the extension of neoplastic cells through the nodal capsule into the perinodal adipose tissue. This histological feature has recently been indicated as an important prognostic factor in different types of malignancies; in this manuscript, we aim at defining its role in the prognosis of oesophageal cancer with the tool of meta-analysis. Two independent authors searched SCOPUS and PubMed until 31 August 2015 without language restrictions. The studies with available data about prognostic parameters in subjects with oesophageal cancer, comparing patients with the presence of ENE (ENE+) versus only intranodal extension (ENE-), were considered as eligible. Data were summarised using risk ratios (RRs) for number of deaths/ recurrences and HRs together with 95% CIs for timedependent risk related to ENE+, adjusted for potential confounders. Fourteen studies were selected; they followed-up 1437 patients with oesophageal cancer for a median follow-up of 39.4 months. The presence of ENE was associated with a significantly increased risk of all-cause mortality (RR=1.33; 95% CI 1.18 to 1.50, p<0.0001, I2=49%; HR=2.72, 95% CI 2.03 to 3.64, p<0.0001, I2=0%), cancer-specific mortality (RR=1.35; 95% CI 1.14 to 1.59, p=0.001, I2=57%; HR=1.97, 95% CI 1.41 to 2.75, p<0.0001, I2=41%) and of risk of recurrence (RR=1.50, 95% CI 1.20 to 1.88, p<0.0001, I2=9%; HR=2.27, 95% CI 1.72 to 2.90, p<0.0001, I2=0%). On the basis of these results, in oesophageal cancer, ENE should be considered from the gross sampling to the pathology report, and in future oncological staging system.

AB - The extranodal extension (ENE) of nodal metastasis is the extension of neoplastic cells through the nodal capsule into the perinodal adipose tissue. This histological feature has recently been indicated as an important prognostic factor in different types of malignancies; in this manuscript, we aim at defining its role in the prognosis of oesophageal cancer with the tool of meta-analysis. Two independent authors searched SCOPUS and PubMed until 31 August 2015 without language restrictions. The studies with available data about prognostic parameters in subjects with oesophageal cancer, comparing patients with the presence of ENE (ENE+) versus only intranodal extension (ENE-), were considered as eligible. Data were summarised using risk ratios (RRs) for number of deaths/ recurrences and HRs together with 95% CIs for timedependent risk related to ENE+, adjusted for potential confounders. Fourteen studies were selected; they followed-up 1437 patients with oesophageal cancer for a median follow-up of 39.4 months. The presence of ENE was associated with a significantly increased risk of all-cause mortality (RR=1.33; 95% CI 1.18 to 1.50, p<0.0001, I2=49%; HR=2.72, 95% CI 2.03 to 3.64, p<0.0001, I2=0%), cancer-specific mortality (RR=1.35; 95% CI 1.14 to 1.59, p=0.001, I2=57%; HR=1.97, 95% CI 1.41 to 2.75, p<0.0001, I2=41%) and of risk of recurrence (RR=1.50, 95% CI 1.20 to 1.88, p<0.0001, I2=9%; HR=2.27, 95% CI 1.72 to 2.90, p<0.0001, I2=0%). On the basis of these results, in oesophageal cancer, ENE should be considered from the gross sampling to the pathology report, and in future oncological staging system.

UR - http://www.scopus.com/inward/record.url?scp=84978828807&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978828807&partnerID=8YFLogxK

U2 - 10.1136/jclinpath-2016-203830

DO - 10.1136/jclinpath-2016-203830

M3 - Article

AN - SCOPUS:84978828807

JO - Journal of Clinical Pathology - Clinical Molecular Pathology

JF - Journal of Clinical Pathology - Clinical Molecular Pathology

SN - 0021-9746

ER -